NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

Apple

(AAPL) - Get Report

rated new Neutral at Nomura. $710 price target. Growth could decelerate by 2014.

Allot Communications

(ALLT) - Get Report

upgraded at Jefferies to Buy from Hold, Jefferies said. $30 price target. Verizon will soon begin ramping.

Aruba Networks

(ARUN)

upgraded to hold at TheStreet Ratings.

HomeAway

(AWAY)

upgraded to hold at TheStreet Ratings.

Cardinal Health

(CAH) - Get Report

upgraded at ISI from Market Weight to Overweight, ISI Group said. $46 price target. Stock is already factoring in pricing fears with WAG and CVS.

Caterpillar

(CAT) - Get Report

rated new Neutral at Piper. $90 price target. Mining segment is a long term strength, but an overhang in 2013.

Cymer

(CYMI)

rated new Outperform at CLSA. $60 price target. Leading stepper light source supplier.

Dell

(DELL) - Get Report

rated new Sell at Citigroup. $8.50 price target. BYOD trends should pressure shares.

DirecTV

(DTV)

downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. $58 price target. Company will likely buy back fewer shares in the coming quarters.

Edison International

(EIX) - Get Report

downgraded at Jefferies to Hold from Buy, Jefferies said. $51 price target. Valuation call.

Evercore Partners

(EVR) - Get Report

rated new Neutral at UBS. $28 price target. Dilution risk could limit support the yield provides to the stock.

Greenhill

(GHL) - Get Report

rated new Neutral at UBS. $52 price target. Premium valuations restored, further upside seems limited.

Hewlett-Packard

(HPQ) - Get Report

rated new Sell at Citigroup. $13.50 price target. Needs clear strategic direction and leadership.

IBM

(IBM) - Get Report

rated new Buy at Citigroup. $250 price target. One of the most compelling long term investments in tech.

Johnson & Johnson

(JNJ) - Get Report

downgraded at Goldman from Neutral to Sell, Goldman Sachs said. Valuation call, based on a $72 price target.

Lazard

(LAZ) - Get Report

rated new Sell at UBS. $25 price target. Solid mature business, but valuation and expectations stretched.

Eli Lilly

(LLY) - Get Report

upgraded at Goldman from Sell to Neutral, Goldman Sachs said. $54 price target. Sola could reach the market in 3 to 4 years.

Netflix

(NFLX) - Get Report

downgraded at BofA/Merrill from Buy to Underperform, Bank of America/Merrill Lynch said. $72 price target. Valuation call, as the stock is up 31% over the past two weeks.

PACCAR

(PCAR) - Get Report

rated new Overweight at Piper. $48.50 price target. Best positioned to benefit from a return to growth in the North American truck market.

Pier 1 Imports

(PIR) - Get Report

rated new Buy at Deutsche. $25 price target. Company is leveraged to positive industry trends.

Progressive

(PRGS) - Get Report

downgraded at Mizuho from Buy to Neutral, Mizuho said. $14.50 price target. Company is losing a key leader, which it will struggle to replace.

Pioneer Natural

(PXD) - Get Report

rated new Outperform at Wells. Wolfcamp play should drive near-term growth.

Questcor Pharmaceuticals

(QCOR)

upgraded at Jefferies to Buy from Hold, Jefferies said. $28 price target. Limited downside with improved visibility.

Vertex Pharmaceuticals

(VRTX) - Get Report

rated new Buy at Deutsche. $77 price target. New cystic fibrosis drug should be the next main driver.

STOCK COMMENTS / EPS CHANGES

Moody's

(MCO) - Get Report

estimates, target increased at Piper.MCO estimates were raised through 2013, Piper Jaffray said. Company is leveraged to higher debt issuance rates. Overweight rating and new $55 price target.

Pentair

(PNR) - Get Report

estimates, target raised at Credit Suisse. Shares of PNR now seen reaching $54, according to Credit Suisse. Estimates also increased, as the Tyco deal should add to earnings. Neutral rating.

Riverbed

(RVBD)

estimates, target boosted at ThinkEquity. Shares of RVBD now seen reaching $26, according to ThinkEquity. Estimates also upped, given higher expected demand and pricing. Buy rating.

>To submit a news tip, email:

tips@thestreet.com

.

READERS ALSO LIKE:

>>10 Best Apple Products Ever

>>The Sad Story of Jack Welch in Retirement: Opinion

Follow

TheStreet

on

Twitter

and become a fan on

Facebook.

This article was written by a staff member of TheStreet.